Western blotting indicated that the expressions both of Bax and Casepase 9 were robustly elevated, whereas that of Bcl2 was decreased in gypenoside-treated bladder cancer cells compared to that in the control groups (Figures 5(f) and 5(g)). The gene discussed is BAX; the disease is urinary bladder carcinoma.